Nano-X Imaging Ltd.
NNOXHealthcareNASDAQMedical Devices · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Nano-X Imaging Ltd. focuses on Medical Devices services and products. Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The $29.3M market capitalization puts NNOX squarely in micro-cap range for its industry. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications.
Market Cap
$29.3M
Beta
1.26
P/E (TTM)
—
P/E (Fwd)
-0.93
EPS (TTM)
$-1.71
EPS (Fwd)
$-0.40
ROE
-99.0%
ROA
-27.9%
Cash
$31.0M
Total Debt
$7.7M
Free CF
-$30.8M
52W Change
-90.7%
Annual Financials
Cash vs Debt
Where NNOX stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, NNOX finished 70.50% below its 150-day moving average ($1.39) and 76.16% below its 200-day moving average ($1.72). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NNOX overbought or oversold?
At the October 20, 2026 close, NNOX's RSI(14) was 14.4, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $31.0M in cash and $7.7M in debt, NNOX maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow is running at -$30.8M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -99.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $8.6M (2022) to $13.0M (2025), reflecting a 52% increase over the period.
With cash comfortably exceeding debt, NNOX has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Nano-X Imaging Ltd. and its sector.